The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 VNUS MEDICAL TECHNOL  (VNUS) Trade Now »     Rate VNUS  -  Discuss VNUS  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Medical Equipment & Supplies
This is a micro-cap stock and may be a target of manipulation. Always do your research!

SocialPicks Sentiment:
N/A

** not enough data to be rated 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate VNUS:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

VNUS: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

Stem Cell & Regenerative Medicine Stocks Surge in Past Month Graphic_rating_buy VNUS
Mikerun
73%

Stem Cell & Regenerative Medicine Stocks Surge in Past Month

<>
The accompanying table [click to enlarge] includes the Top 10 Rated companies among a total of 64 and statistics for the ETF Innovators [ETFI] Cosmetic and Reconstructive Medicine [CRM] Index, which includes companies with market caps over $100M engaged in cosmetic medicine products, regenerative medicine + stem cells, orthopedic repair, joint replacements, and cardiovascular (heart + blood vessels) treatments.

The Top 10 Rated companies are dominated by those focusing on cardiovascular treatments...
By  Mike Havrilla   (+1.04%  risk: conservative)  12/20/08 Comment




From the Blogosphere

Notable Mergers and Acquisitions of the Day 5/8: COV/VNUS
<> <>Covidien (NYSE: COV) reached a definitive agreement to acquire VNUS Medical Technologies, Inc. (NASDAQ: VNUS) for $29 per share, or $440 million net of cash.Shares of VNUS closed at $21.32 yesterday.Assuming a second calendar quarter closing, Covidien expects this transaction to dilute fiscal 2009 GAAP earnings per share, primarily due to a one-time charge for in-process research and development (IPR&D). On a non-GAAP basis, excluding IPR&D, the transaction is expected to be slightly dilutive to 2009 earnings per share; however, the underlying strength of Covidien’s existing businesses is ...
By  Street Insider   (+16.72%  risk: moderate)  05/08/09 Comment


Medical research: Small cap duo
16%

Small cap expert Jim Oberweis, Jr. looks to two medical stocks; in The Oberweis Report, he eyes one firm focused on venous reflex disease and another that is treating fibromyalgia.

"VNUS Medical Technologies (NASDAQ: VNUS) is a leading provider of medical devices for the minimally invasive treatment of venous reflux disease.

"This is a progressive condition caused by incompetent vein valves in the legs. Venous reflux disease results in symptoms such as leg pain, swelling, fatigue, skin ulcers and painful varicose veins.

<>"The company’s primary product line, the VNUS Closure system, c<><><><><><><><><><><><><><>< />...
By  The Stock Advisors   (-13.15%  risk: moderate)  04/13/09 Comment


Stem Cell & Regenerative Medicine Stocks Surge in Past Month
Mikerun
73%

The accompanying table [click to enlarge] includes the Top 10 Rated companies among a total of 64 and statistics for the ETF Innovators [ETFI] Cosmetic and Reconstructive Medicine [CRM] Index, which includes companies with market caps over $100M engaged in cosmetic medicine products, regenerative medicine + stem cells, orthopedic repair, joint replacements, and cardiovascular (heart + blood vessels) treatments.

The Top 10 Rated companies are dominated by those focusing on cardiovascular treatments, including VNUS Medical Technologies (VNUS), Thoratec (THOR), Edwards Lifesciences (EW), Vascul...
By  Mike Havrilla   (+1.04%  risk: conservative)  12/20/08 Comment


Trading Ideas: Waxing Positive Graphic_rating_buy VNUS
Cc_logo
49%
We have been downbeat and sticking to the short side for many of our recent recommendations here at The Correct Call. Today we are going to buck that trend and get positive on a high-growth stock. Sometimes you have to look at the world’s glass as being half full and today is one of those days. Vnus [...]
By  The Correct Call   (+2.69%  risk: moderate)  07/01/08 Comment


Thursday's Upgrades and Downgrades
 2 %
<>
Upgrades
US Airways (LCC)- Credit Suisse Underperform » Neutral
UAL Corp. (UAUA)- Credit Suisse Neutral » Outperform
Whole Foods (WFMI)- FTN Midwest Neutral » Buy
Eli Lilly (LLY)- Cowen & Co Neutral » Outperform
Amdocs (DOX)- Kaufman Bros Hold » Buy
Novartis AG (NVS)- Cowen & Co Neutral » Outperform
Novatel Wireless (NVTL)- Morgan Joseph Hold » Buy
SAIC (SAI)- Jesup & Lamont Neutral » Buy
Prestige Brands (PBH)- Oppenheimer Underperform » Perform
Morgan Stanley (MS)- Wachovia Mkt Perform » Outperform
Tyson Foods (TSN)- Wachovia Mkt Perform ...
By  Todd Sullivan   (-23.07%  risk: aggressive)  06/05/08 Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +33.23% 420
2 Gerald Greene 18.14 +56.22% 236
3 stockmarketfunding.com 17.66 +24.06% 63
4 akiralegrand 13.47 +14.32% 65
5 anup2104 12.13 +93.46% 54


POPULAR STOCKS
Symbol Company Name Sentiment
PG The Procter & Gamble Company
FRE Freddie Mac
SBUX Starbucks Corp
SIRI Sirius Satellite Radio Inc
BIDU Baiducom Inc ADS
GLD streetTRACKS Gold

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on VNUS

Visit streetinsider.com


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About VNUS MEDICAL TECHNOL - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch